JIANG, Feng-E. Efficacy and safety of regorafenib or fruquintinib plus camrelizumab in patients with microsatellite stable and/or proficient mismatch repair metastatic colorectal cancer: an observational pilot study. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2021, 2021, vol. 68, no. 4, s. 861-866.